For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
-
Narrated by:
-
By:
About this listen
Featuring perspectives from Dr Christopher Flowers, Dr Manali Kamdar, Ms Robin Klebig and Ms Caitlin Murphy, including the following topics:
- Introduction: Overview of Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma (0:00)
- Current and Future Use of Bruton Tyrosine Kinase Inhibitors for Mantle Cell Lymphoma (16:09)
- First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) (40:03)
- Role of Loncastuximab Tesirine for Patients with Relapsed/Refractory (R/R) DLBCL (57:31)
- Role of Tafasitamab for Patients with R/R DLBCL and Follicular Lymphoma (1:16:59)
NCPD information and select publications
No reviews yet